vs
Astrana Health, Inc.（ASTH）与飞塔（FTNT）财务数据对比。点击上方公司名可切换其他公司
飞塔的季度营收约是Astrana Health, Inc.的1.9倍（$1.8B vs $950.5M），飞塔净利率更高（28.9% vs 0.7%，领先28.2%），Astrana Health, Inc.同比增速更快（42.9% vs 20.1%），飞塔自由现金流更多（$1.0B vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 13.6%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
飞塔（Fortinet）是总部位于美国加利福尼亚州森尼韦尔的网络安全企业，专注于研发与销售防火墙、终端安全、入侵检测系统等各类网络安全产品，目前在美国、加拿大、英国等多个国家设有办事机构。
ASTH vs FTNT — 直观对比
营收规模更大
FTNT
是对方的1.9倍
$950.5M
营收增速更快
ASTH
高出22.8%
20.1%
净利率更高
FTNT
高出28.2%
0.7%
自由现金流更多
FTNT
多$1.0B
$-6.0M
两年增速更快
ASTH
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.8B |
| 净利润 | $6.6M | $534.5M |
| 毛利率 | — | 80.3% |
| 营业利润率 | 1.9% | 31.4% |
| 净利率 | 0.7% | 28.9% |
| 营收同比 | 42.9% | 20.1% |
| 净利润同比 | 184.4% | — |
| 每股收益（稀释后） | $0.12 | $0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHFTNT
| Q1 26 | — | $1.8B | ||
| Q4 25 | $950.5M | $1.9B | ||
| Q3 25 | $956.0M | $1.7B | ||
| Q2 25 | $654.8M | $1.6B | ||
| Q1 25 | $620.4M | $1.5B | ||
| Q4 24 | $665.2M | $1.7B | ||
| Q3 24 | $478.7M | $1.5B | ||
| Q2 24 | $486.3M | $1.4B |
净利润ASTHFTNT
| Q1 26 | — | $534.5M | ||
| Q4 25 | $6.6M | $506.0M | ||
| Q3 25 | $373.0K | $473.9M | ||
| Q2 25 | $9.4M | $440.1M | ||
| Q1 25 | $6.7M | $433.4M | ||
| Q4 24 | $-7.8M | $526.2M | ||
| Q3 24 | $16.1M | $539.9M | ||
| Q2 24 | $19.2M | $379.8M |
毛利率ASTHFTNT
| Q1 26 | — | 80.3% | ||
| Q4 25 | — | 79.6% | ||
| Q3 25 | — | 80.8% | ||
| Q2 25 | — | 80.7% | ||
| Q1 25 | — | 81.0% | ||
| Q4 24 | — | 81.1% | ||
| Q3 24 | — | 82.5% | ||
| Q2 24 | — | 80.8% |
营业利润率ASTHFTNT
| Q1 26 | — | 31.4% | ||
| Q4 25 | 1.9% | 32.8% | ||
| Q3 25 | 2.0% | 31.7% | ||
| Q2 25 | 3.1% | 28.1% | ||
| Q1 25 | 3.3% | 29.5% | ||
| Q4 24 | 0.1% | 34.6% | ||
| Q3 24 | 5.9% | 31.2% | ||
| Q2 24 | 6.2% | 30.5% |
净利率ASTHFTNT
| Q1 26 | — | 28.9% | ||
| Q4 25 | 0.7% | 26.6% | ||
| Q3 25 | 0.0% | 27.5% | ||
| Q2 25 | 1.4% | 27.0% | ||
| Q1 25 | 1.1% | 28.1% | ||
| Q4 24 | -1.2% | 31.7% | ||
| Q3 24 | 3.4% | 35.8% | ||
| Q2 24 | 3.9% | 26.5% |
每股收益（稀释后）ASTHFTNT
| Q1 26 | — | $0.72 | ||
| Q4 25 | $0.12 | $0.67 | ||
| Q3 25 | $0.01 | $0.62 | ||
| Q2 25 | $0.19 | $0.57 | ||
| Q1 25 | $0.14 | $0.56 | ||
| Q4 24 | $-0.14 | $0.68 | ||
| Q3 24 | $0.33 | $0.70 | ||
| Q2 24 | $0.40 | $0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $3.3B |
| 总债务越低越好 | — | $496.8M |
| 股东权益账面价值 | $779.3M | $989.7M |
| 总资产 | $2.2B | $9.9B |
| 负债/权益比越低杠杆越低 | — | 0.50× |
8季度趋势，按日历期对齐
现金及短期投资ASTHFTNT
| Q1 26 | — | $3.3B | ||
| Q4 25 | $429.5M | $2.5B | ||
| Q3 25 | $463.4M | $2.0B | ||
| Q2 25 | $342.1M | $3.4B | ||
| Q1 25 | $260.9M | $3.6B | ||
| Q4 24 | $290.8M | $2.9B | ||
| Q3 24 | $350.3M | $2.5B | ||
| Q2 24 | $327.7M | $2.2B |
总债务ASTHFTNT
| Q1 26 | — | $496.8M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASTHFTNT
| Q1 26 | — | $989.7M | ||
| Q4 25 | $779.3M | $1.2B | ||
| Q3 25 | $775.5M | $735.1M | ||
| Q2 25 | $765.5M | $2.1B | ||
| Q1 25 | $745.4M | $2.0B | ||
| Q4 24 | $712.7M | $1.5B | ||
| Q3 24 | $704.6M | $908.1M | ||
| Q2 24 | $678.9M | $288.2M |
总资产ASTHFTNT
| Q1 26 | — | $9.9B | ||
| Q4 25 | $2.2B | $10.4B | ||
| Q3 25 | $2.2B | $9.4B | ||
| Q2 25 | $1.4B | $10.6B | ||
| Q1 25 | $1.3B | $10.4B | ||
| Q4 24 | $1.4B | $9.8B | ||
| Q3 24 | $1.3B | $8.9B | ||
| Q2 24 | $1.3B | $8.1B |
负债/权益比ASTHFTNT
| Q1 26 | — | 0.50× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $1.1B |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $1.0B |
| 自由现金流率自由现金流/营收 | -0.6% | 54.4% |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 2.02× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $2.4B |
8季度趋势，按日历期对齐
经营现金流ASTHFTNT
| Q1 26 | — | $1.1B | ||
| Q4 25 | $-2.9M | $620.2M | ||
| Q3 25 | $10.0M | $655.2M | ||
| Q2 25 | $90.9M | $451.9M | ||
| Q1 25 | $16.6M | $863.3M | ||
| Q4 24 | $-10.9M | $477.6M | ||
| Q3 24 | $34.0M | $608.1M | ||
| Q2 24 | $23.2M | $342.0M |
自由现金流ASTHFTNT
| Q1 26 | — | $1.0B | ||
| Q4 25 | $-6.0M | $577.4M | ||
| Q3 25 | $7.4M | $567.5M | ||
| Q2 25 | $89.5M | $284.1M | ||
| Q1 25 | $13.6M | $796.8M | ||
| Q4 24 | $-13.5M | $380.0M | ||
| Q3 24 | $31.7M | $571.8M | ||
| Q2 24 | $20.4M | $318.9M |
自由现金流率ASTHFTNT
| Q1 26 | — | 54.4% | ||
| Q4 25 | -0.6% | 30.3% | ||
| Q3 25 | 0.8% | 32.9% | ||
| Q2 25 | 13.7% | 17.4% | ||
| Q1 25 | 2.2% | 51.8% | ||
| Q4 24 | -2.0% | 22.9% | ||
| Q3 24 | 6.6% | 37.9% | ||
| Q2 24 | 4.2% | 22.2% |
资本支出强度ASTHFTNT
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.2% | ||
| Q3 25 | 0.3% | 5.1% | ||
| Q2 25 | 0.2% | 10.3% | ||
| Q1 25 | 0.5% | 4.3% | ||
| Q4 24 | 0.4% | 5.9% | ||
| Q3 24 | 0.5% | 2.4% | ||
| Q2 24 | 0.6% | 1.6% |
现金转化率ASTHFTNT
| Q1 26 | — | 2.02× | ||
| Q4 25 | -0.44× | 1.23× | ||
| Q3 25 | 26.69× | 1.38× | ||
| Q2 25 | 9.65× | 1.03× | ||
| Q1 25 | 2.48× | 1.99× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | 2.11× | 1.13× | ||
| Q2 24 | 1.21× | 0.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FTNT
| Service | $1.2B | 65% |
| Product | $645.1M | 35% |
